|Bid||49.85 x 900|
|Ask||49.95 x 1200|
|Day's Range||48.55 - 50.39|
|52 Week Range||40.94 - 61.71|
|Beta (5Y Monthly)||0.62|
|PE Ratio (TTM)||9.75|
|Forward Dividend & Yield||1.60 (3.19%)|
|Ex-Dividend Date||Jul 28, 2022|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for PFE
MARKET PULSE Pfizer Inc. (pfe) CEO Albert Bourla tested positive for COVID-19. He tweeted Monday that he received four shots of the COVID-19 vaccine the company developed with BioNTech SE (bntx) is "experiencing very mild symptoms" and has started taking Paxlovid, Pfizer's COVID-19 antiviral.
The Pfizer CEO says he has received four doses of his company’s Covid-19 vaccine. Albert Bourla said he had begun taking a course of Paxlovid, his company’s Covid-19 antiviral.
Pfizer Inc Chief Executive Officer Albert Bourla said on Monday he had tested positive for COVID-19 and was experiencing very mild symptoms. Bourla, 60, said he had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions. "I am confident that I will have a speedy recovery," Bourla said in a statement.